Congestive heart failure in Indians: how do we improve diagnosis & management?

Indian J Med Res · 2010 · PMC3028953 · PMID 21150007

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

All cause mortality at the end of the monotherapy phase showed a non significant 28 per cent risk reduction in favour of bisoprolol first at the end of the monotherapy phase and a borderline significant 31 per cent risk reduction in favour of bisoprolol first up to one year.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.